CareFusion To Provide Update On Form 10-K Filing On Dec. 19

SAN DIEGO, Dec. 17, 2012 /PRNewswire/ -- CareFusion Corporation (NYSE: CFN) plans to provide an update on Wednesday, Dec. 19 regarding progress toward filing its Form 10-K for fiscal 2012 and Form 10-Q for the quarter ended Sept. 30.

As previously disclosed, the company is in the process of modifying the manner in which it applies lease accounting principles to sales-type leases in its Pyxis® medication and supply dispensing product lines and assessing any impact on its financial statements. This matter does not affect CareFusion customers or the underlying fundamentals and cash flows of the company or its Pyxis business.

On Nov. 8, the company said it would provide an update on the matter in approximately one month. As a result, CareFusion will host a webcast and conference call on Dec. 19 at 5 a.m. PST (8 a.m. EST).  

To access the Dec. 19 call, visit the Investors page at www.carefusion.com. Log on at least 15 minutes before the call begins to register and download or install any necessary audio software. Investors and other interested parties may also access the call by dialing (800) 510-0146 within the U.S. or (617) 614-3449 from outside the U.S., using the access code 64995265. A replay of the conference call will be available from 7 a.m. PST on Dec. 19. through 11:59 p.m. PST on Dec. 26 and can be accessed by dialing (888) 286-8010 in the U.S. or (617) 801-6888 internationally and using the access code 67989805.

About CareFusion
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife™ and LTV® series ventilation and respiratory products, ChloraPrep® skin prep products, MedMined® services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at http://www.carefusion.com/.

SOURCE CareFusion Corporation